Simvastatin-corax

Simvastatin-corax may be available in the countries listed below.

Ingredient matches for Simvastatin-corax

Simvastatin

Simvastatin is reported as an ingredient of Simvastatin-corax in the following countries:

• Germany

International Drug Name Search

Alzytec

Alzytec may be available in the countries listed below.

Ingredient matches for Alzytec

Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Alzytec in the following countries:

• Singapore

International Drug Name Search

Dotium

Dotium may be available in the countries listed below.

Ingredient matches for Dotium

Domperidone

Domperidone maleate (a derivative of Domperidone) is reported as an ingredient of Dotium in the following countries:

• Vietnam

International Drug Name Search

Terbinafina Combix

Terbinafina Combix may be available in the countries listed below.

Ingredient matches for Terbinafina Combix

Terbinafine

Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Terbinafina Combix in the following countries:

• Spain

International Drug Name Search

Aciclovir

UK matches:

• Aciclovir 200mg/5ml Oral Suspension
• Aciclovir Cream 5% (Actavis UK Ltd)
• Aciclovir Suspension 400mg/5ml (Rosemont Pharmaceuticals Ltd)
• Aciclovir Tablets 200mg, 400mg, 800mg (Actavis UK Ltd)
• Aciclovir Tablets BP
• Aciclovir 200mg/5ml Oral Suspension (SPC)
• Aciclovir 25 mg/ml Sterile Concentrate (SPC)
• Aciclovir 250mg Powder for Solution for Infusion (Wockhardt UK Ltd) (SPC)
• Aciclovir 400mg/5ml Oral Suspension (SPC)
• Aciclovir Cream 5% (SPC)
• Aciclovir Cream 5% w/w (Pharmacia Limited) (SPC)
• ACICLOVIR TABLETS BP 200mg (SPC)
• Aciclovir Tablets BP 400mg (SPC)
• Aciclovir Tablets BP 800mg (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

D06BB03,J05AB01,S01AD03

CAS registry number (Chemical Abstracts Service)

0059277-89-3

Chemical Formula

C8-H11-N5-O3

Molecular Weight

225

Therapeutic Category

Antiviral agent

Chemical Name

6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-

Foreign Names

• Aciclovirum (Latin)
• Aciclovir (German)
• Aciclovir (French)
• Aciclovir (Spanish)

Generic Names

• Aciclovir (OS: BAN, JAN, DCIT, DCF)
• Acyclovir (OS: USAN)
• ACG (IS)
• ACV (IS)
• Acycloguanosine (IS)
• Aciclovir (PH: BP 2010, Ph. Eur. 6)
• Aciclovirum (PH: Ph. Eur. 6)
• Acyclovir (PH: USP 32)
• Acyclovir Sodium (OS: USAN)
• BW 248 U (IS: Burroughs Wellcome)

Brand Names

• Abduce
  Farmanic Chemipharma, Greece



• Acerpes
  Investi, Argentina; Riemser, Germany



• Acevir
  AC Farma, Peru



• Acic Cream
  Rowex, Ireland



• Acic
  Hexal, Bulgaria; Hexal, Bahrain; Hexal, Germany; Hexal, Luxembourg; Hexal, Oman; Salutas, Georgia; Salutas, Lithuania; Sandoz, Estonia; Sandoz, Latvia



• Acic-Ophtal
  Winzer, Germany



• Acic-Fieberblasencreme
  Hexal, Austria



• Aciclin
  Fidia, Italy



• Aciclo Ahimsa
  Ahimsa, Argentina



• Aciclo Basics
  Basics, Germany



• Aciclobene ratiopharm
  Ratiopharm, Austria



• Aciclobene
  Ratiopharm, Austria



• Aciclobeta
  Betapharm, Germany



• Aciclo-CT
  CT Arzneimittel, Germany



• Aciclodan
  Pharmacodane, Denmark



• Aciclomed
  Ranbaxy, Belgium



• Aciclomerck
  Mylan Pharmaceutical, Japan



• Aciclor
  Leti, Venezuela



• Aciclosina
  Cipan, Portugal



• Aciclostad Topico
  VP, Spain



• Aciclostad
  Stada, Austria; Stada, Germany; Stada, Georgia; VP, Spain



• Aciclotabs Actavis
  Actavis, Estonia



• Aciclovax
  Labesfal, Portugal



• Aciclovin
  Nichi-Iko PharmaceuticalJMA, Japan



• Aciclovir 1A Farma
  1A Farma, Denmark



• Aciclovir ABC
  ABC, Italy



• Aciclovir Actavis
  Actavis, Bulgaria; Actavis, Denmark; Actavis, France; Actavis, Italy; Actavis, Lithuania; Actavis, Latvia; Actavis, Netherlands



• Aciclovir Aguettant
  Aguettant, France



• Aciclovir akut Creme-1 A Pharma
  1A Pharma, Germany



• Aciclovir AL
  Aliud, Czech Republic; Aliud, Germany; Aliud, Hungary; Aliud, Slovakia



• Aciclovir Almus
  Almus, France; Almus, Italy



• Aciclovir Alter
  Alter, France; Alter, Italy



• Aciclovir Alterna
  Alterna Farmaceutici, Italy



• Aciclovir Apotex
  Apotex, Belgium



• Aciclovir Aristo
  Aristo Pharma, Germany



• Aciclovir Arrow
  Arrow, France



• Aciclovir Best
  Best, Colombia



• Aciclovir Bestpharma
  Bestpharma, Peru



• Aciclovir Bexal
  Bexal, Spain



• Aciclovir Big
  Benedetti, Italy



• Aciclovir Biogaran
  Biogaran, France



• Aciclovir Centrum
  Centrum, Spain



• Aciclovir CF
  Centrafarm, Netherlands



• Aciclovir Ciclum
  Ciclum, Portugal



• Aciclovir Cinfa
  Cinfa, Spain



• Aciclovir Cream
  Actavis, Georgia



• Aciclovir Creme-1A Pharma
  1A Pharma, Germany



• Aciclovir CristerS
  CristerS, France



• Aciclovir Cuvefarma
  Cuvefarma, Spain



• Aciclovir Dakota Pharm
  Dakota Pharm, France



• Aciclovir DBL
  Hospira, Singapore



• Aciclovir DOC
  DOC Generici, Italy



• Aciclovir Dorom
  Dorom, Italy



• Aciclovir Edigen
  Edigen, Spain



• Aciclovir EG
  EG, Italy; EG Labo, France; Eurogenerics, Belgium; Eurogenerics, Luxembourg



• Aciclovir Genericon
  Genericon, Austria



• Aciclovir Generis
  Generis, Portugal



• Aciclovir Genfar
  Expofarma, Chile; Genfar, Colombia; Genfar, Ecuador; Genfar, Peru



• Aciclovir Germed
  Germed Pliva, Italy



• Aciclovir Heumann
  Heumann, Germany



• Aciclovir Hexal
  Hexal, Italy; Hexal, Russian Federation; Hexal A/S, Denmark



• Aciclovir Hospira
  Hospira, Belgium



• Aciclovir Intravenous Infusion
  PfizerPerth, Australia



• Aciclovir Jet
  Jet, Italy



• Aciclovir Katwijk
  Apotex Europe, Netherlands



• Aciclovir Kela
  Kela, Belgium



• Aciclovir Kern Pharma
  Kern, Spain



• Aciclovir Korhispana
  Korhispana, Spain



• Aciclovir L.CH.
  Chile, Chile



• Aciclovir La Santé
  La Santé, Colombia



• Aciclovir Labesfal
  Labesfal, Portugal



• Aciclovir Lafedar
  Lafedar, Argentina



• Aciclovir LCH
  Ivax, Peru



• Aciclovir Lindopharm
  Lindopharm, Germany



• Aciclovir Mabo
  Mabo, Spain



• Aciclovir Martian
  LKM, Argentina



• Aciclovir Merck
  Merck Genericos, Spain; Merck Génériques, Tunisia



• Aciclovir MK
  Bonima, Belize; Bonima, Costa Rica; Bonima, Guatemala; Bonima, Honduras; Bonima, Nicaragua; Bonima, Panama; Bonima, El Salvador; McKesson, Ecuador; MK, Colombia



• Aciclovir Mundogen
  Mundogen, Spain



• Aciclovir Mylan
  Mylan, Italy



• Aciclovir Northia
  Northia, Argentina



• Aciclovir Opalia
  Opalia, Tunisia



• Aciclovir Pasteur
  Pasteur, Chile



• Aciclovir Pensa
  Pensa, Italy; Pensa Pharma, Spain



• Aciclovir Pharmagenus
  Pharmagenus, Spain



• Aciclovir PHC
  Pharmachemie, Netherlands



• Aciclovir Qualimed
  Qualimed, France



• Aciclovir Ranbaxy
  Ranbaxy, Denmark; Ranbaxy, Spain; Ranbaxy, France; Ranbaxy, Italy



• Aciclovir ratiopharm
  Ratiopharm, France; Ratiopharm, Italy



• Aciclovir Recordati
  Recordati, Italy



• Aciclovir RPG
  RPG, France



• Aciclovir Samenwerkende Apothekers
  Samenwerkende Apothekers, Netherlands



• Aciclovir Sandoz
  Sandoz, Australia; Sandoz, Belgium; Sandoz, France; Sandoz, Italy; Sandoz, Netherlands; Sandoz, Portugal; Sandoz, Sweden



• Aciclovir Siga
  Sigapharm, Germany



• Aciclovir Solka
  Solka, Costa Rica; Solka, Dominican Republic; Solka, Honduras; Solka, Nicaragua; Solka, El Salvador



• Aciclovir Stada
  Stada, Spain



• Aciclovir T.S.
  Farmaceutici T.S., Italy



• Aciclovir Tablets
  Actavis, Georgia



• Aciclovir Tedec
  Tedec Meiji, Spain



• Aciclovir Teva
  Teva, Belgium; Teva, Italy; Teva Santé, France



• Aciclovir Topico Alonga
  Sanofi-Aventis S.A., Spain



• Aciclovir Topico Centrum
  Centrum, Spain



• Aciclovir Topico Combix
  Combix, Spain



• Aciclovir Topico Cuve
  Cuvefarma, Spain



• Aciclovir Topico Edigen
  Edigen, Spain



• Aciclovir Topico Kern Pharma
  Kern, Spain



• Aciclovir Topico Korhispana
  Korhispana, Spain



• Aciclovir Topico Mabo
  Mabo, Spain



• Aciclovir Topico Merck
  Merck Genericos, Spain



• Aciclovir Topico Mundogen
  Mundogen, Spain



• Aciclovir Topico Pensa
  Pensa Pharma, Spain



• Aciclovir Topico Pharmagenus
  Pharmagenus, Spain



• Aciclovir Topico Ranbaxy
  Ranbaxy, Spain



• Aciclovir Topico Stada
  Stada, Spain



• Aciclovir Topico Teva
  Teva, Spain



• Aciclovir Torlan
  Torlan, France



• Aciclovir Vocate
  Vocate, Greece



• Aciclovir Winthrop
  Sanofi-Aventis, France; Winthrop, Portugal



• Aciclovir Zydus
  Zydus, France



• Aciclovir
  AC Farma, Peru; Actavis, Estonia; Actavis, United Kingdom; American Generics, Peru; Arena, Romania; Behrens, Venezuela; Biogen, Peru; Biogen, Peru; Chemopharma, Chile; Colmed, Peru; CP, Malta; Ecuaquímica, Ecuador; Egis, Romania; Elter - Medicamentos Genéricos, Venezuela; Farmindustria, Peru; Farmo Andina, Peru; G&R, Peru; Gedeon Richter, Romania; Genamerica, Ecuador; Genéricos Venezolanos, Venezuela; GenRx, Netherlands; Genthon, Netherlands; GlaxoSmithKline, Netherlands; GMP, Georgia; Grünenthal, Peru; Hospira, United Kingdom; Hospira, Netherlands; Induquimica, Peru; IPhSA, Chile; Jelfa, Poland; Kwang Mayung Pharma, Ethiopia; La Sante, Peru; Lansier, Peru; Laropharm, Romania; LCG, Peru; Leidapharm, Netherlands; Lek, Bosnia & Herzegowina; Marfan, Peru; Mayne, Netherlands; Mintlab, Chile; Nizhpharm, Russian Federation; OFA, Venezuela; Ozone Laboratories, Romania; Pentacoop, Colombia; Pentacoop, Peru; Perugen, Peru; Pfizer, Chile; Polinac, Venezuela; Quilab, Peru; Ranbaxy, Netherlands; Rosemont, United Kingdom; Terapia, Romania; Terbol, Peru; UQP, Peru; Vivax, Venezuela; Wockhardt, United Kingdom; Wockhardt, Georgia; Wockhardt, United States



• Aciclovir-1A Pharma
  1A Pharma, Austria; 1A Pharma, Germany



• Aciclovir-200-von-Ct
  CT, Luxembourg



• Aciclovir-800-von-Ct
  CT, Luxembourg



• Aciclovir-Akri
  Akrihin, Russian Federation



• Aciclovirax
  Hessel, Guatemala; Hessel, Honduras; Hessel, Panama; Hessel, El Salvador



• Aciclovir-CT
  CT Arzneimittel, Germany; Tempelhof, Luxembourg



• Aciclovir-Eurogenerics
  Eurogenerics, Luxembourg



• Aciclovir-Genthon
  Genthon, Luxembourg



• Aciclovir-Glaxo Wellcome
  GlaxoSmithKline, Luxembourg



• Aciclovir-Mayne
  Hospira, Luxembourg



• Aciclovir-ratiopharm
  Ratiopharm, Belgium; Ratiopharm, Germany; Ratiopharm, Netherlands; Ratiopharm, Portugal



• Acifar
  Ifars, Indonesia



• Aciherp
  TAD, Luxembourg



• Acihexal
  Sandoz, Australia



• Aciklam
  Actavis, Lithuania



• Aciklovir Stada
  Stada, Sweden



• Aciklovir
  Remevita, Serbia; Zdravlje, Serbia



• Acilomin
  Medisa Shinyaku, Japan



• Acirovec
  Sawai Seiyaku, Japan



• Acitab DT
  Cipla Medpro, South Africa



• Acitop
  Cipla Medpro, South Africa



• Acivir
  Cipla, Australia; Cipla, Ethiopia; Cipla, Israel; Cipla, India; Cipla, Latvia; Cipla, Oman; Pharmacodane, Denmark; Spirig Pharma, Switzerland; Unifarma, Latvia; Nichi-Iko PharmaceuticalJMA, Japan



• Acivirex
  Mediproducts, Guatemala; Mediproducts, Nicaragua; Mediproducts, El Salvador



• Acivirol
  Farmacoop, Colombia



• AciVision
  OmniVision, Germany



• Acix
  Sandoz, Poland



• Aclovirax
  Marching Pharmaceutical, Hong Kong



• Actidas
  Shiono Kemikaru, Japan



• Actios
  Taiyo Pharmaceutical, Japan



• Activir
  GlaxoSmithKline, Austria; GlaxoSmithKline, France; GlaxoSmithKline, South Africa



• Acy
  Farmigea, Italy



• Acyclostad Galmed
  Stada, Slovakia



• Acyclostad
  Stada, Bulgaria; Stada, Estonia; Stada, Finland; Stada, Georgia; Stada, Hungary; Stada, Lithuania; Stada, Latvia; Stada, Netherlands



• Acyclo-V
  Alphapharm, Australia; CTS, Israel



• Acyclovid
  Pharmimpex, Georgia



• Acyclovir Al
  Aliud, Slovakia



• Acyclovir and Hydrocortione (Aciclovir and Hydrocortisone)
  Medivir, United States



• Acyclovir Denk
  Denk Pharma, Ethiopia



• Acyclovir Domesco
  Domesco, Vietnam



• Acyclovir Helvepharm
  Helvepharm, Switzerland



• Acyclovir Sodium
  Baxter Healthcare, United States; Teva USA, United States



• Acyclovir Stada
  Stada, Bulgaria; Stada, Estonia; Stada, Hong Kong; Stada, Latvia; Stada, Poland; Stada, Singapore; Stada, Taiwan; Stada, Vietnam



• Acyclovir
  Actavis, United States; Apotex, United States; Belcher, United States; Bristol-Myers Squibb, United States; Carlsbad, United States; Dae Hwa Pharmaceuticals, Ethiopia; Dava, United States; GAMA, Georgia; Genpharm, United States; GMP, Georgia; Hi-Tech, United States; Medicalex, Colombia; Meditrend, Israel; Ranbaxy, United States; Stason, United States; Teva USA, United States; Watson, United States



• Acyclovir-Mepha
  Mepha Pharma, Switzerland



• Acyclovir-Teva
  Teva, Israel; Teva, Latvia



• Acycril
  I'rom SeiyakuAiromu, Japan



• Acyl
  Biofarma Pharmaceuticals, Ethiopia; Münir Sahin, Turkey



• Acyrax
  Orion, Finland



• Acyrovin
  Seoul Pharma, Myanmar



• Acyvir
  Apotec, Hong Kong; Aristopharma, Bangladesh; Glaxo Allen, Italy; H.G., Ecuador



• Adco-Acyclovir
  Adcock Ingram Pharmaceuticals, South Africa



• Ailax
  Tatsumi Kagaku, Japan



• Airnurse
  Toko Pharmaceutical, Japan



• Aklovir
  Sandoz, Turkey



• Alovir
  Caber, Italy



• Amitrox
  Pharmathen, Greece



• Amodivyr
  Copernico, Italy



• Anti
  Antula, Sweden



• Antivir
  Sanofi-Aventis, Poland



• Antix
  Antula, Finland; Antula, Norway



• Apo-Acyclovir
  Apotex, Canada; Apotex, Guyana; Apotex, New Zealand; Apotex, Singapore



• Apofarm
  Gezzi, Argentina



• Asiclo
  Asiatic Lab, Bangladesh



• Asiviral
  Terra, Turkey



• Aspen Acyclovir
  Aspen Pharmacare, South Africa



• Astric
  Nippon Kayaku, Japan



• Avir
  Roemmers, Venezuela



• Aviral
  Mepha, Bahrain; Mepha Pharma, Switzerland



• Avirase
  Lampugnani, Italy



• Avirox
  Sandoz, Denmark



• Avix
  Ibirn, Italy



• Avorax
  Pan Pharma, Sri Lanka; Xepa-Soul Pattinson, Hong Kong; Xepa-Soul Pattinson, Singapore



• Avyclor
  Farma1, Italy



• Avyplus
  Epifarma, Italy



• Awirol
  ICN, Poland



• Bearax
  Beacons, Singapore



• Bel Labial
  Nycomed, Spain



• Bellvirax
  Ranbaxy, Ireland



• Blistex
  Key, Australia



• Cargosil
  Genepharm, Greece; Genepharm, Romania



• Cevinolon
  Bros, Greece



• Cevirin
  Esseti Farmaceutici, Ethiopia



• Chemists' Own Cold Sore Cream
  Chemists, Australia



• Chemmart Aciclovir
  Apotex, Australia



• Ciclavix
  Luper, Brazil



• Cicloferon
  Liomont, Dominican Republic; Liomont, Guatemala; Liomont, Mexico; Liomont, Panama; Liomont, El Salvador; Polysan, Georgia



• Cicloviral
  Incobra, Colombia; Medinfar, Portugal



• Citivir
  CT, Georgia



• Clinovir
  Pharos, Indonesia



• Clirbest
  Best, Mexico



• Clopes
  Metiska, Indonesia



• Cloryvil GMP
  Giempi, Venezuela



• Clovate
  Pola Pharma, Japan



• Clovimix
  Amex, Peru



• Clovir
  Ibn Sina, Bangladesh; Spimaco, Bahrain; Spimaco, Oman



• Cloviral
  Antibiotice, Romania



• Cloviran
  Bestpharma, Chile



• Clovirax
  Pharmalliance, Algeria; Remek, Greece



• Cloviril
  Bassa, Peru



• Clyvorax
  Unipharm, Mexico



• Compaclovir
  Bioindustria, Ecuador



• Cusiviral
  Alcon, Bahrain; Alcon, Hong Kong; Alcon, Oman; Alcon Cusi, Poland; Alcon Cusi, Singapore



• Cyclivex
  Aspen Pharmacare, South Africa



• Cyclomed
  Medibrands, Israel



• Cyclostad
  Stada, Philippines



• Cyclovax
  Ebewe, Hong Kong; Remedica, Cyprus



• Cyclovex
  Opso Saline, Bangladesh



• Cyclovir
  Cadila, Bahrain; Cadila, Sri Lanka; Cadila Gehört zu Zydus, India; Cadila Health Care, Ethiopia; Zydus, Russian Federation



• Cycloviran Medichrom
  Medichrom, Greece



• Cycloviran
  Sigma Tau, Italy



• Danovir
  Kalbe, Indonesia



• Declovir
  Hoe, Myanmar; Hoe Pharmaceuticals, Ethiopia



• Dioxis
  Hexa, Argentina



• Doc Aciclo
  Docpharma, Luxembourg



• Docaciclo
  Docpharma, Belgium; Docpharma, Luxembourg



• Dravyr
  Drug Research, Italy; Drug Research, Singapore



• Dynexan Herpescreme
  Kreussler, Germany



• Ecuvir
  ECU, Ecuador



• Efriviral
  Aesculapius, Italy



• Elvirax
  Malaysia Chemist, Singapore



• Entir
  Unison, Hong Kong; Unison, Myanmar; Unison, Singapore



• Erlvirax
  Malaysia Chemist, Singapore



• Erpaclovir
  Alapis Pharma, Greece



• Erpizon
  Demo, Greece



• Esavir
  B&G, Italy



• Etasisen
  Rafarm, Greece



• Euroclovir
  Europharm, Hong Kong



• Eurovir
  Saval Eurolab, Chile



• Euvirox
  Europharm, Romania



• Fada Aciclovir
  Fada, Argentina



• Fuviron
  Proge, Italy



• Geavir
  Hexal A/S, Denmark; Sandoz, Sweden



• Gen-Acyclovir
  Genpharm, Canada



• GenRX Aciclovir
  Apotex, Australia



• Grosparl
  Takata Seiyaku, Japan



• Hagevir
  Cosmopharm, Greece



• Hascovir
  Hasco, Poland



• Helposol
  Help, Greece



• Helvevir
  Helvepharm, Switzerland



• Herax
  Novell, Indonesia



• Hermixsofex
  Sofex, Portugal



• Hermocil
  Edol, Portugal



• Hernovir
  Nobel, Bosnia & Herzegowina; Nobel, Turkey



• Herpavir
  TAD, Denmark



• Herpelad
  Searle Pharmaceuticals, Ethiopia; TAD, Ethiopia



• Herpelans
  Olainfarm, Latvia



• Herperax
  Micro Labs, Sri Lanka; Micro Labs, Myanmar



• Herpesil
  Hexal, Brazil



• Herpesin
  Lachema, Czech Republic; Lachema, Romania; Pliva, Bosnia & Herzegowina; Pliva, Hungary; Pliva, Romania; Pliva, Slovakia



• Herpesnil
  Sofar, Italy



• Herpetad
  TAD, Luxembourg; TAD, El Salvador



• Herpevir
  Laboratories Omega Pharma, France



• Herpex
  Edol, Portugal; Sandoz, Poland; Torrent, Bahrain; Torrent, India; Torrent Pharmaceuticals, Ethiopia



• Herpial
  Uriach, Spain



• Herpiclof
  Nufarindo, Indonesia



• Herpin
  Cafar, Venezuela



• Herpleks
  Belupo, Bosnia & Herzegowina



• Herplex
  Belupo, Croatia (Hrvatska)



• Herpolips
  Berner, Finland



• HerpoMed
  S.Med, Austria



• Herzkur
  Chrispa, Greece



• Heviran
  Polpharma, Latvia



• Iliaclor
  Medifarma, Italy



• Immunovir
  Alta Care, Malta



• Klovir
  Biofarma, Venezuela; Dr Reddys, Myanmar



• Koortslip DA
  DA, Netherlands



• Koortslip Etos
  Etos, Netherlands



• Koortslip HTP
  Healthypharm, Netherlands



• Koortslip SDG
  SDG, Netherlands



• Laciken
  Kendrick, Mexico



• Licovir
  Berlico Mulia Farma, Indonesia



• Lippenherpescreme elac
  Dermapharm, Germany



• Lisovyr
  Elea, Argentina; Mintlab, Chile



• Lovir
  Douglas, New Zealand; Genepharm, Australia; Ranbaxy, Oman; Ranbaxy, Peru; Ranbaxy, Romania; Ranbaxy, Singapore



• Lovire
  Ranbaxy, South Africa



• Lovrak
  Julphar, Oman



• Mapox
  Niddapharm, Luxembourg



• Maynar Labial
  Novag, Spain



• Medovir
  Medochemie, Bahrain; Medochemie, Cyprus; Medochemie, Ethiopia; Medochemie, Hong Kong; Medochemie, Iraq; Medochemie, Jordan; Medochemie, Sri Lanka; Medochemie, Malta; Medochemie, Russian Federation; Medochemie, Sudan; Medochemie, Singapore; Medochemie, Taiwan; Medochemie, Yemen



• Menova
  Avsa, Peru



• Mevirox
  Medis, Tunisia



• Molavir
  Molex Ayus, Indonesia



• Natazil
  Fuji Yakuhin, Japan



• Neldim
  Vilco, Greece



• Neviran
  SF, Italy



• Nockwoo Acyclovir
  Welfide, Vietnam



• Novirax
  Drug International, Bangladesh; Oman Pharmaceutical Products - OPP, Oman



• Novirex
  Drug International, Bangladesh



• Nu-Acyclovir
  Nu-Pharm, Canada



• Oftavir
  Saval Nicolich, Chile



• Opthavir
  Grin, Mexico



• Ozvir
  Ranbaxy, Australia



• Palovir
  Pharmacore Labs, Indonesia



• Pharex Aciclovir
  Pascual, Philippines



• Pharmaniaga Aciclovir
  Pharmaniaga, Malaysia



• Pharrax
  Kyorin Rimedio, Japan



• Poviral
  Hexpharm Jaya, Indonesia; Kalbe Farma, Myanmar; Roemmers, Argentina



• Provirsan
  Pro.Med.CS, Bosnia & Herzegowina; Pro.Med.CS, Czech Republic; Pro.Med.CS, Estonia; Pro.Med.CS, Georgia; Pro.Med.CS, Latvia; Pro.Med.CS, Slovakia



• Pulibex
  Mentinova, Greece



• Qualiclovir
  Quality, Hong Kong



• Quavir
  Soho, Indonesia



• Ranvir
  Ranbaxy, Czech Republic



• ratio-Acyclovir
  ratiopharm, Canada



• Remex
  Genévrier, France



• Rexan
  Istituto Chim. Internazionale, Italy



• Riduvir
  Francia, Italy



• Roidil
  Acromax, Ecuador



• Sanavir
  Mayne, Italy



• Scanovir
  Tempo Scan Pacific, Indonesia



• Sevirax
  Gaco, Bangladesh



• Silovir
  Eczacibasi, Turkey



• Simplevir
  Dr. Collado, Dominican Republic



• Sophivir
  Sophia, Costa Rica; Sophia, Dominican Republic; Sophia, Guatemala; Sophia, Honduras; Sophia, Mexico; Sophia, Nicaragua; Sophia, Panama; Sophia, El Salvador



• Supra-Vir
  Trima, Israel



• Supraviran
  Grünenthal, Luxembourg



• Syntovir
  Codal Synto Pharmaceuticals, Ethiopia



• Telviran
  Egis, Hungary; Egis, Slovakia



• Temiral
  Sanbe, Indonesia



• Terry White Chemists Aciclovir
  Apotex, Australia



• Tomill
  Tanabe Mitsubishi, Japan



• Uniclovyr
  Roster, Peru



• Uniplex
  Uni-Pharma, Greece



• Vacrax
  Samchully, Singapore



• Vercusron
  Towa Yakuhin, Japan



• Verpir
  Kleva, Greece



• Vicclox
  Kobayashi Kako, Japan



• Vidaclovir
  Vida, Hong Kong



• Vilerm
  Siam Bheasach, Thailand



• Viraban
  AFT, New Zealand



• Viralex
  Ariston, Ecuador



• Viralief
  Clonmel, Ireland



• Viralis
  Global Multi Pharmalab, Indonesia



• Viratac
  Multichem, New Zealand



• Viratop
  Apotex, Belgium



• Vircovir
  Corsa Industries, Indonesia



• Virest
  Hovid, Hong Kong; Hovid, Philippines; Hovid, Singapore



• Virestat
  Liferpal, Mexico



• Vireth
  Ethica Industri Farmasi, Indonesia



• Virex
  Biogen, Colombia; Raserpharm, Ecuador



• Virherpes Forte
  Laboratorios Dr Esteve, Spain



• Virherpes Topico
  Laboratorios Dr Esteve, Spain



• Virine
  Nipa, Bangladesh



• Virless
  Yung Shin, Singapore



• Virlex
  Nippon Tenganyaku KenkyujoNitten, Japan



• Virmen Topico
  Menarini, Spain



• Viroclear
  Christo Pharmaceutical, Hong Kong



• Virolex
  Krka, Bosnia & Herzegowina; Krka, Georgia; Krka, Croatia (Hrvatska); Krka, Hungary; Krka, Lithuania; Krka, Latvia; Krka, Poland; Krka, Romania; Krka, Slovenia; Krka, Slovakia



• ViroMed
  S.Med, Austria



• Vironida LCH
  Ivax, Peru



• Vironida
  Chile, Chile



• Virosil
  Saba, Turkey



• Virostatic
  Pablo Cassara, Argentina



• Viroxi
  Eskayef, Bangladesh



• Virpes
  Advanced Pharmaceutical Industries, Oman



• Virtaz
  Fahrenheit, Indonesia



• Virucalm
  Zambon, Switzerland



• Virucid
  Aegis, Malta; Universal Pharmaceutical, Hong Kong



• Viruderm
  Cinfa, Spain



• Viruhexal
  Sandoz, Japan



• Virulax Heumann
  Heumann, Germany



• Virules
  Kimia Farma, Indonesia



• Virupos
  Biem, Turkey; Ursapharm, Germany



• Viru-Pos
  Ursapharm, Poland



• Virusan
  Inti, Peru



• Virustat
  Ram Pharmaceutical, Oman



• Virusteril
  Biospray, Greece



• Virux
  Square, Bangladesh



• Virzin
  Dermapharm, Germany



• Vivir
  Hanmi, Myanmar



• Vivorax
  Cadila, Georgia; Cadila, Russian Federation; Cadila Health Care, Ethiopia



• Vizocross
  Taisho Yakuhin, Japan



• Voraclor
  Lafare, Italy



• Vyrohexal
  Hexal, South Africa



• Xiclovir
  Lazar, Argentina



• Xorovir
  Kwizda, Poland



• Xorox
  Agepha, Austria



• Your Pharmacy Aciclovir
  Orion, Australia



• Zeramil
  Elpen, Greece



• Zevin
  Biolab, Hong Kong



• Zidovimm
  Anfarm, Greece



• Zinolium Aciclovir
  Nycomed, Netherlands



• Zirconia
  Wermar, Mexico



• Ziverone
  Rayere, Mexico



• Zobiatron
  Tsuruhara Seiyaku, Japan



• Zobiclobill
  Nihon Seiyaku, Japan



• Zobistat
  Choseido Pharmaceutical, Japan



• Zoliparin
  Mann, Germany



• Zoral
  DHA, Hong Kong; DHA, Singapore



• Zorax
  Sunward, Singapore



• Zoraxin
  Duopharma, Hong Kong



• Zoter
  Interbat, Indonesia



• Zov 800
  Glaxo Wellcome, Portugal



• Zovicrem Labial
  GlaxoSmithKline Consumer Healthcare, Spain



• Zovir
  GlaxoSmithKline, Denmark; GlaxoSmithKline, Iceland



• Zovirax Labial
  Wellcome, Spain



• Zovirax Lip
  GlaxoSmithKline, Switzerland



• Zovirax Oftalmico
  Glaxo SmithKline, Spain



• Zovirax Ofthalmic Ointment
  GlaxoSmithKline, Hong Kong; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Taiwan



• Zovirax Ophthalmic Ointment
  GlaxoSmithKline, South Africa



• Zovirax Topico
  GlaxoSmithKline Consumer Healthcare, Spain



• Zovirax
  Biovail, United States; Draxis, Serbia; GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Antigua & Barbuda; GlaxoSmithKline, Netherlands Antilles; GlaxoSmithKline, Argentina; GlaxoSmithKline, Austria; GlaxoSmithKline, Australia; GlaxoSmithKline, Aruba; GlaxoSmithKline, Barbados; GlaxoSmithKline, Bangladesh; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Bermuda; GlaxoSmithKline, Brazil; GlaxoSmithKline, Bahamas; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Chile; GlaxoSmithKline, Costa Rica; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Dominican Republic; GlaxoSmithKline, Ecuador; GlaxoSmithKline, Estonia; GlaxoSmithKline, Ethiopia; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Grenada; GlaxoSmithKline, Georgia; GlaxoSmithKline, Greece; GlaxoSmithKline, Guatemala; GlaxoSmithKline, Guyana; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Honduras; GlaxoSmithKline, Hungary; GlaxoSmithKline, Indonesia; GlaxoSmithKline, Israel; GlaxoSmithKline, India; GlaxoSmithKline, Iran; GlaxoSmithKline, Italy; GlaxoSmithKline, Jamaica; GlaxoSmithKline, Japan; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Cayman Islands; GlaxoSmithKline, Saint Lucia; GlaxoSmithKline, Sri Lanka; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Latvia; GlaxoSmithKline, Malta; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Nicaragua; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Panama; GlaxoSmithKline, Peru; GlaxoSmithKline, Qatar; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, El Salvador; GlaxoSmithKline, Thailand; GlaxoSmithKline, Tunisia; GlaxoSmithKline, Turkey; GlaxoSmithKline, Trinidad & Tobago; GlaxoSmithKline, Taiwan; GlaxoSmithKline, United States; GlaxoSmithKline, Vietnam; GlaxoSmithKline, South Africa; GlaxoSmithKline Consumer Healthcare, Croatia (Hrvatska); GlaxoSmithKline Consumer Healthcare, Netherlands; GlaxoSmithKline Consumer Healthcare, Poland; GlaxoSmithKline Consumer Healthcare, Sweden; Wellcome, Ireland



• Zoviraxlabiale
  GlaxoSmithKline, Italy



• Zoylex
  Dropesac, Peru; Kope Trading, Peru; Korea United, Myanmar



• Zyclir
  Sigma, Australia



• Zyclorax
  Mugi Laboratories, Indonesia



• Zyvir
  Cadila, Kenya



• Acic
  Hexal, Luxembourg



• Aciclobene Pulver
  Ratiopharm, Austria



• Aciclovir Combino Pharm
  Combino, Spain



• Aciclovir Filaxis
  Filaxis, Argentina



• Aciclovir Genfarma
  Genfarma, Spain



• Aciclovir Ges
  Ges Genericos, Spain



• Aciclovir Hospira
  Hospira, Finland; Hospira Nordic, Sweden



• Aciclovir Intravenous Infusion DBL
  Hospira, Australia; Mayne, Hong Kong



• Aciclovir Labatec
  Labatec, Switzerland



• Aciclovir Mayne
  Hospira, Norway; Hospira Nordic, Denmark



• Aciclovir Mylan
  Mylan, France



• Aciclovir Sala
  Ramon, Spain



• Aciclovir Sandoz
  Sandoz, Spain



• Aciclovir
  Filaxis, Argentina; Mayne, New Zealand



• Aciclovir-ratiopharm
  Ratiopharm, Germany



• Acivir
  DeltaSelect, Germany



• Acyclovir Abbott
  Abbott, Thailand



• Acyclovir Sodium Injection
  Hospira, Canada



• Acyclovir Sodium
  APP, United States; Bedford, United States; Sicor, United States



• Acyclovir-Mepha i.v.
  Mepha Pharma, Switzerland



• Acyrax
  Orion, Finland



• DBL Aciclovir
  Hospira, New Zealand



• Erpizon
  Demo, Greece



• Geavir
  Hexal A/S, Denmark; Sandoz, Sweden



• Herpesin
  Pliva, Czech Republic; Pliva, Hungary; Pliva, Slovakia; Pliva Lachema, Poland



• Heviran
  Polpharma, Poland



• Klovireks-L
  Mustafa Nevzat, Turkey



• Supraviran
  Grünenthal, Germany; Grünenthal, Oman



• Virherpes
  Pensa, Spain



• Virolex
  Krka, Croatia (Hrvatska); Krka, Hungary



• Xorox
  Kwizda, Romania



• Zovir
  GlaxoSmithKline, Iceland



• Zovirax
  Glaxo SmithKline, Spain; Glaxo Wellcome, Portugal; GlaxoSmithKline, Antigua & Barbuda; GlaxoSmithKline, Netherlands Antilles; GlaxoSmithKline, Aruba; GlaxoSmithKline, Barbados; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bermuda; GlaxoSmithKline, Brazil; GlaxoSmithKline, Bahamas; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Costa Rica; GlaxoSmithKline, Germany; GlaxoSmithKline, Dominican Republic; GlaxoSmithKline, Estonia; GlaxoSmithKline, Finland; GlaxoSmithKline, Grenada; GlaxoSmithKline, Guatemala; GlaxoSmithKline, Guyana; GlaxoSmithKline, Honduras; GlaxoSmithKline, Jamaica; GlaxoSmithKline, Cayman Islands; GlaxoSmithKline, Saint Lucia; GlaxoSmithKline, Mexico; GlaxoSmithKline, Nicaragua; GlaxoSmithKline, Netherlands; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Panama; GlaxoSmithKline, Peru; GlaxoSmithKlin

Omalizumab

Pronunciation: OH-ma-LIZ-oo-mab
Generic Name: Omalizumab
Brand Name: Xolair

Omalizumab may rarely cause a severe and sometimes life-threatening allergic reaction. This may occur right after receiving a dose or hours later. It may occur after the first dose or after many doses. Your doctor will monitor you for a period of time after your receive your dose of Omalizumab. Contact your doctor or seek medical care at once if you develop anxiety; chest tightness; cough; dizziness; fainting; fast or weak heartbeat; feeling unusually warm; flushing; hives; hoarseness; itching; rash; shortness of breath; swelling of the mouth, face, lips, tongue, or throat; trouble breathing; trouble swallowing; or wheezing.

Omalizumab is used for:

Treating moderate to severe persistent asthma in certain patients who have had a positive allergy skin test and whose symptoms are not controlled by inhaled corticosteroids.

Omalizumab is an anti-immunoglobulin E (IgE) monoclonal antibody. It works by blocking your immune system's natural response to allergens, which can lead to an acute asthma attack. This action on the immune system (specifically, IgE) helps keep your air passages open and, over time, keeps asthma under better control.

Do NOT use Omalizumab if:

• you are allergic to any ingredient in Omalizumab

Contact your doctor or health care provider right away if this applies to you.

Before using Omalizumab:

Some medical conditions may interact with Omalizumab. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances, including murine proteins


• if you have severe bronchospasms or are currently taking other medicines for asthma


• if you have a history of cancer


• if you will be traveling to areas where exposure to a parasitic infection (eg, roundworm, hookworm) is possible

Some MEDICINES MAY INTERACT with Omalizumab. However, no specific interactions with Omalizumab are known at this time.

Ask your health care provider if Omalizumab may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Omalizumab:

Use Omalizumab as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Omalizumab comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Omalizumab refilled.


• Omalizumab is usually given as an injection at your doctor's office, hospital, or clinic.


• If you miss a dose of Omalizumab or you are unable to keep your doctor's appointment, contact your doctor right away.

Ask your health care provider any questions you may have about how to use Omalizumab.

Important safety information:

• Omalizumab may cause dizziness. This effect may be worse if you take it with alcohol or certain medicines. Use Omalizumab with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Talk with your doctor or pharmacist about all of your asthma medicines and how to use them. Do not start, stop, or change the dose of any asthma medicine unless your doctor tells you to.


• Omalizumab will not stop an asthma attack once one has started.


• The dosage is based on your body weight and blood level of IgE antibody, as well as your medical condition and response to therapy. Contact your doctor if you have a significant change in body weight during treatment. Your dose may need to be adjusted.


• It may take several months for Omalizumab to work.


• Use caution if you switch from an oral steroid (eg, prednisone) to Omalizumab. It may take several months for your body to make enough natural steroids to handle events that cause physical stress. Such events may include injury, surgery, infection, loss of blood electrolytes, or a sudden asthma attack. These may be severe and sometimes fatal. Contact your doctor right away if any of these events occur. You may need to take an oral steroid (eg, prednisone) again. Carry a card at all times that says you may need an oral steroid (eg, prednisone) if any of these events occur.


• Omalizumab may increase the levels of IgE in your blood during therapy and for up to 1 year after discontinuing use of Omalizumab. Be sure your doctor and lab personnel know you are taking Omalizumab.


• Lab tests may be performed while you use Omalizumab. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Omalizumab should be used with extreme caution in CHILDREN younger than 12 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Omalizumab while you are pregnant. It is not known if Omalizumab is found in breast milk. If you are or will be breast-feeding while you use Omalizumab, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Omalizumab:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Bruising, itching, pain, redness, stinging, swelling, or warmth at the injection site; headache; itching and swelling of the skin; leg, arm, or ear pain; sinus inflammation.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, tongue or throat); anxiety; calf pain, swelling, or tenderness; chest pain; confusion; cough; dizziness; fainting; fast, weak, or irregular heartbeat; feeling unusually warm; flushing; hoarseness; new or worsening breathing problems or shortness of breath; numbness or tingling; one-sided weakness; speech problems; swelling of a vein; symptoms of sinus or lung infection (congestion, cough, or fever); trouble swallowing; unusual bruising or bleeding; unusual lumps, growths, or moles; unusual swelling of the hands or feet; vision problems; wheezing.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Omalizumab side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Omalizumab:

Omalizumab is usually handled and stored by a health care provider. If you are using Omalizumab at home, store Omalizumab as directed by your pharmacist or health care provider. Keep Omalizumab out of the reach of children and away from pets.

General information:

• If you have any questions about Omalizumab, please talk with your doctor, pharmacist, or other health care provider.


• Omalizumab is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Omalizumab. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Omalizumab resources

• Omalizumab Side Effects (in more detail)
• Omalizumab Use in Pregnancy & Breastfeeding
• Omalizumab Drug Interactions
• Omalizumab Support Group
• 9 Reviews for Omalizumab - Add your own review/rating

• Omalizumab Professional Patient Advice (Wolters Kluwer)


• Omalizumab Monograph (AHFS DI)


• omalizumab Subcutaneous Advanced Consumer (Micromedex) - Includes Dosage Information


• Xolair Prescribing Information (FDA)


• Xolair Consumer Overview

Compare Omalizumab with other medications

• Asthma, Maintenance

Agnicin

Agnicin may be available in the countries listed below.

Ingredient matches for Agnicin

Amikacin

Amikacin sulfate (a derivative of Amikacin) is reported as an ingredient of Agnicin in the following countries:

• Mexico

International Drug Name Search

Alfavet

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Alfavet

Alfaprostol

Alfaprostol is reported as an ingredient of Alfavet in the following countries:

• United States

International Drug Name Search

Bactelan

Bactelan may be available in the countries listed below.

Ingredient matches for Bactelan

Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Bactelan in the following countries:

• Mexico

Trimethoprim

Trimethoprim is reported as an ingredient of Bactelan in the following countries:

• Mexico

International Drug Name Search

Cépazine

Cépazine may be available in the countries listed below.

Ingredient matches for Cépazine

Cefuroxime

Cefuroxime axetil (a derivative of Cefuroxime) is reported as an ingredient of Cépazine in the following countries:

• France

International Drug Name Search

Sotalol Basics

Sotalol Basics may be available in the countries listed below.

Ingredient matches for Sotalol Basics

Sotalol

Sotalol hydrochloride (a derivative of Sotalol) is reported as an ingredient of Sotalol Basics in the following countries:

• Germany

International Drug Name Search

Propioform

Propioform may be available in the countries listed below.

Ingredient matches for Propioform

Betamethasone

Betamethasone 17α,21-dipropionate (a derivative of Betamethasone) is reported as an ingredient of Propioform in the following countries:

• Greece

International Drug Name Search

Perforated Tympanic Membrane Medications

There are currently no drugs listed for "Perforated Tympanic Membrane".

Definition of Perforated Tympanic Membrane: A tear in the Tympanic membrane (eardrum).

Learn more about Perforated Tympanic Membrane

Micromedex Care Notes:

• Laceration
• Tympanic Membrane Perforation

Medical Encyclopedia:

• Ear emergencies
• Ruptured eardrum

Drug List:

Sandoz Co-Amoxyclav

Sandoz Co-Amoxyclav may be available in the countries listed below.

Ingredient matches for Sandoz Co-Amoxyclav

Amoxicillin

Amoxicillin is reported as an ingredient of Sandoz Co-Amoxyclav in the following countries:

• South Africa

Clavulanate

Clavulanic Acid is reported as an ingredient of Sandoz Co-Amoxyclav in the following countries:

• South Africa

International Drug Name Search

Adonamin

Adonamin may be available in the countries listed below.

Ingredient matches for Adonamin

Carbazochrome

Carbazochrome sodium sulfonate (a derivative of Carbazochrome) is reported as an ingredient of Adonamin in the following countries:

• Japan

International Drug Name Search

Laxans-ratiopharm Pico

Laxans-ratiopharm Pico may be available in the countries listed below.

Ingredient matches for Laxans-ratiopharm Pico

Sodium Picosulfate

Sodium Picosulfate monohydrate (a derivative of Sodium Picosulfate) is reported as an ingredient of Laxans-ratiopharm Pico in the following countries:

• Germany

International Drug Name Search

Aldinir

Aldinir may be available in the countries listed below.

Ingredient matches for Aldinir

Cefdinir

Cefdinir is reported as an ingredient of Aldinir in the following countries:

• Vietnam

International Drug Name Search

Herpelad

Herpelad may be available in the countries listed below.

Ingredient matches for Herpelad

Acyclovir

Aciclovir is reported as an ingredient of Herpelad in the following countries:

• Ethiopia

International Drug Name Search

Filosfil

Filosfil may be available in the countries listed below.

Ingredient matches for Filosfil

Nelfinavir

Nelfinavir mesilate (a derivative of Nelfinavir) is reported as an ingredient of Filosfil in the following countries:

• Argentina

International Drug Name Search

Flea-Fence Acute

Flea-Fence Acute may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Flea-Fence Acute

Nitenpyram

Nitenpyram is reported as an ingredient of Flea-Fence Acute in the following countries:

• Netherlands

International Drug Name Search

Acemetacin-CT

Acemetacin-CT may be available in the countries listed below.

Ingredient matches for Acemetacin-CT

Acemetacin

Acemetacin is reported as an ingredient of Acemetacin-CT in the following countries:

• Germany

International Drug Name Search

Proparacaine Hydrochloride

Ingredient matches for Proparacaine Hydrochloride

Proxymetacaine

Proparacaine Hydrochloride (USAN) is also known as Proxymetacaine (Rec.INN)

International Drug Name Search

Glossary

Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Prophylux

Prophylux may be available in the countries listed below.

Ingredient matches for Prophylux

Propranolol

Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Prophylux in the following countries:

• Germany

International Drug Name Search

Aci-End

Aci-End may be available in the countries listed below.

Ingredient matches for Aci-End

Magaldrate

Magaldrate is reported as an ingredient of Aci-End in the following countries:

• Peru

Simeticone

Simeticone is reported as an ingredient of Aci-End in the following countries:

• Peru

International Drug Name Search

Acetylsalicylzuur Katwijk

Acetylsalicylzuur Katwijk may be available in the countries listed below.

Ingredient matches for Acetylsalicylzuur Katwijk

Aspirin

Acetylsalicylic Acid is reported as an ingredient of Acetylsalicylzuur Katwijk in the following countries:

• Netherlands

International Drug Name Search

Sicovit C

Sicovit C may be available in the countries listed below.

Ingredient matches for Sicovit C

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Sicovit C in the following countries:

• Romania

International Drug Name Search

Swine Wormer B

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Swine Wormer B

Pyrantel

Pyrantel tartrate (a derivative of Pyrantel) is reported as an ingredient of Swine Wormer B in the following countries:

• United States

International Drug Name Search

Piam

Piam may be available in the countries listed below.

Ingredient matches for Piam

Tetryzoline

Tetryzoline hydrochloride (a derivative of Tetryzoline) is reported as an ingredient of Piam in the following countries:

• Argentina

International Drug Name Search

Oseltamivir Phosphate

Oseltamivir Phosphate may be available in the countries listed below.

Ingredient matches for Oseltamivir Phosphate

Oseltamivir

Oseltamivir Phosphate (USAN) is known as Oseltamivir in the US.

International Drug Name Search

Glossary

USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Cilazapril Teva

Cilazapril-Teva may be available in the countries listed below.

Ingredient matches for Cilazapril-Teva

Cilazapril

Cilazapril monohydrate (a derivative of Cilazapril) is reported as an ingredient of Cilazapril-Teva in the following countries:

• France


• Slovakia

International Drug Name Search

Diliter

Diliter may be available in the countries listed below.

Ingredient matches for Diliter

Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Diliter in the following countries:

• Italy

Duloxetine

Duloxetine is reported as an ingredient of Diliter in the following countries:

• Bangladesh

International Drug Name Search

Biocanispot

Biocanispot may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Biocanispot

Imidacloprid

Imidacloprid is reported as an ingredient of Biocanispot in the following countries:

• France

International Drug Name Search

Bacitracin Injection

Bacitracin for Injection, USP

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Bacitracin and other antibacterial drugs, Bacitracin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

For Intramuscular Use

Warning

Nephrotoxicity: Bacitracin in parenteral (intramuscular) therapy may cause renal failure due to tubular and glomerular necrosis. Its use should be restricted to infants with staphylococcal pneumonia and empyema when due to organisms shown to be susceptible to bacitracin. It should be used only where adequate laboratory facilities are available and when constant supervision of the patient is possible.

Renal function should be carefully determined prior to and daily during therapy. The recommended daily dose should not be exceeded and fluid intake and urinary output should be maintained at proper levels to avoid kidney toxicity. If renal toxicity occurs the drug should be discontinued. The concurrent use of other nephrotoxic drugs, particularly streptomycin, kanamycin, polymyxin B, polymyxin E (colistin), and neomycin should be avoided.

Bacitracin Injection Description

Sterile Bacitracin, USP is an antibiotic for intramuscular administration. Bacitracin is derived from cultures of Bacillus subtilis (Tracey). It is a white to pale buff, hygroscopic powder, odorless or having a slight odor. It is freely soluble in water; insoluble in acetone, chloroform, and ether. While soluble in alcohol, methanol, and glacial acetic acid, there is some insoluble residue. It is precipitated from its solutions and inactivated by many of the heavy metals.

The structural formula is:

The molecular formula is: C66H103N17O16S. Bacitracin is comprised of a polypeptide complex and Bacitracin A is the major component in this complex. The molecular weight of Bacitracin A is 1422.71.

Bacitracin Injection - Clinical Pharmacology

Bacitracin exerts pronounced antibacterial action in vitro against a variety of gram-positive and a few gram-negative organisms. However, among systemic diseases, only staphylococcal infections qualify for consideration of bacitracin therapy. Bacitracin is assayed against a standard and its activity is expressed in units, 1 mg having a potency of not less than 50 units.

Susceptibility plate testing: If the Kirby-Bauer method of disk susceptibility is used, a 10 unit bacitracin disk should give a zone of over 13 mm when tested against a bacitracin-susceptible strain of Staphylococcus aureus. Absorption of bacitracin following intramuscular injection is rapid and complete. A dose of 200 or 300 units/kg every 6 hours gives serum levels of 0.2 to 2 mcg/mL in individuals with normal renal function. The drug is excreted slowly by glomerular filtration. It is widely distributed in all body organs and is demonstrable in ascitic and pleural fluids after intramuscular injection.

Indications and Usage for Bacitracin Injection

In accordance with the statements in the "Warning Box", the use of intramuscular bacitracin is limited to the treatment of infants with pneumonia and empyema caused by staphylococci shown to be susceptible to the drug.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Bacitracin and other antibacterial drugs, Bacitracin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Contraindications

This drug is contraindicated in those individuals with a history of previous hypersensitivity or toxic reaction to it.

WARNINGS and PRECAUTIONS

See "Warning Box" for precautions in regard to kidney toxicity associated with intramuscular use of bacitracin.

Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile.

C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.

If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.

Adequate fluid intake should be maintained orally, or if necessary, by parenteral method.

As with other antibiotics, use of this drug may result in overgrowth of nonsusceptible organisms, including fungi. If superinfection occurs, appropriate therapy should be instituted.

Prescribing Bacitracin in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.

There have been reports of anaphylaxis and/or allergic contact dermatitis in patients exposed to Bacitracin in non-approved indications.

Information for Patients

Patients should be counseled that antibacterial drugs, including Bacitracin, should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Bacitracin is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Bacitracin or other antibacterial drugs in the future.

Diarrhea is a common problem caused by antibiotics which usually ends when the antibiotic is discontinued. Sometimes after starting treatment with antibiotics, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as two or more months after having taken the last dose of the antibiotic. If this occurs, patients should contact their physician as soon as possible.

Adverse Reactions

Nephrotoxic reactions—Albuminuria, cylindruria, azotemia. Rising blood levels without any increase in dosage.

Other reactions—Nausea and vomiting. Pain at site of injection. Skin rashes.

Bacitracin Injection Dosage and Administration

TO BE ADMINISTERED INTRAMUSCULARLY ONLY

Infant dose: For infants under 2500 grams—900 units/kg/24 hours in 2 or 3 divided doses. For infants over 2500 grams—1,000 units/kg/24 hours, in 2 or 3 divided doses. Intramuscular injections of the solution should be given in the upper outer quadrant of the buttocks, alternating right and left and avoiding multiple injections in the same region because of the transient pain following injection.

Preparation of Solutions

Should be dissolved in sodium chloride injection containing 2 percent procaine hydrochloride. The concentration of the antibiotic in the solution should not be less than 5,000 units per mL or more than 10,000 units per mL.

Diluents containing parabens should not be used to reconstitute bacitracin; cloudy solutions and precipitate formation have occurred.

Reconstitution of the 50,000 unit vial with 9.8 mL of diluent will result in a concentration of 5,000 units per mL.

Solutions are stable for one week when stored in a refrigerator 2° to 8°C (36° to 46°F).

How is Bacitracin Injection Supplied

Sterile Bacitracin, USP is available in a vial (1's) containing 50,000 units (NDC 0009-0233-01) and as a pack of ten vials (10's) each containing 50,000 units (NDC 0009-0233-03).

Store the unreconstituted product in a refrigerator 2° to 8°C (36° to 46°F).

Rx only

LAB-0026-5.0

September 2010

PRINCIPAL DISPLAY PANEL - One Vial Carton

NDC 0009-0233-01

One Vial

Rx only

Bacitracin for

Injection, USP

For Intramuscular Use

50,000 Units

Pfizer

Distributed by

Pharmacia & Upjohn Co

Division of Pfizer Inc, NY, NY 10017

BACITRACIN  bacitracin  injection, powder, for solution

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0009-0233 Route of Administration INTRAMUSCULAR DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Bacitracin (Bacitracin) Bacitracin 50000 [iU]

Inactive Ingredients Ingredient Name Strength No Inactive Ingredients Found

Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 0009-0233-01 1 VIAL In 1 CARTON contains a VIAL 1 1 VIAL In 1 VIAL This package is contained within the CARTON (0009-0233-01) 2 0009-0233-03 10 VIAL In 1 CARTON contains a VIAL 2 1 VIAL In 1 VIAL This package is contained within the CARTON (0009-0233-03)

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
ANDA	ANDA060733	07/29/1948

Labeler - Pharmacia and Upjohn Company (829076566)

Establishment
Name	Address	ID/FEI	Operations
Pharmacia and Upjohn Company		829076566	MANUFACTURE

Establishment
Name	Address	ID/FEI	Operations
Xellia Pharmaceuticals AS		561816174	MANUFACTURE

Revised: 12/2011Pharmacia and Upjohn Company